Saniona to participate in multiple upcoming virtual investor conferences
PRESS RELEASE
January5, 2022
Saniona (OMX: SANION), a clinical-stage biopharmaceutical company focused on rare diseases, today announcedthat it will present at multiple upcoming virtual investor conferences. Details are as follows:
LifeSci Partners 11th Annual Corporate Access Event (Panel and 1:1 Meetings)
Date/Time: 6 January 2022, 2:00 p.m. ET / 20.00 CET
Presenter: Rami Levin, President and CEO
Panel Webcast Link: https://wsw.com/webcast/lifesci3/panel10/2456850
Aktiespararna Digital Share Evening
Date/Time: 12 January 2022, 1:00pm ET / 19.00 CET
Presenter: Trista Morrison, Chief Communications Officer
Website Link: https://www.aktiespararna.se/aktiviteter/digitala-aktiekvallen-12-januari-2022
HC Andersen Capital Company Introduction
Date/Time: 19 January 2022, 9:00 a.m. ET / 15.00 CET
Presenter: Rami Levin, President and CEO
Webcast Link: https://hcandersencapital643.clickmeeting.com/saniona-company-introduction/register
Aktieportföljen Live
Date/Time: 8 February 2022, 8:45 a.m. ET / 14.45 CET
Presenter: Trista Morrison, Chief Communications Officer
Website Link: Not yet available
As presenting times and live webcast links become available, they will be shared on the Saniona website in the Events & Presentations section: https://ir.saniona.com/events-and-presentations. Live webcasts will be available at the links provided. Subsequently, the recorded webcast events will be archived for approximately 90 days on Saniona’s website.
For more information, please contact
Trista Morrison, Chief Communications Officer, Saniona. Office: + 1 (781) 810-9227. Email: trista.morrison@saniona.com
The information was submitted for publication, through the agency of the contact person set out above, at 16:45 CET on 5January2022.
About Saniona
Saniona is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for patients suffering from rare diseases for which there are a lack of available treatment options. The company’s lead product candidate, Tesomet, is in mid-stage clinical trials for hypothalamic obesity and Prader-Willi syndrome, serious rare disorders characterized by severe weight gain, disturbances of metabolic functions and uncontrollable hunger. Saniona has developed a proprietary ion channel drug discovery engine anchored by IONBASE™, a database of more than 130,000 compounds, of which more than 20,000 are Saniona’s proprietary ion channel modulators. Through its ion channel expertise, Saniona is advancing two wholly-owned ion channel modulators, SAN711 and SAN903. SAN711 is in a Phase 1 clinical trial and may be applicable in the treatment of rare neuropathic disorders, and SAN903 is in preclinical development for rare inflammatory, fibrotic and hematological disorders. Led by an experienced scientific and operational team, Saniona has an established research organization in the Copenhagen area, Denmark, and a corporate office in the Boston, Massachusetts area, U.S. The company’s shares are listed on Nasdaq Stockholm Small Cap (OMX: SANION). Read more at http://www.saniona.com.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Forløb af ordinær generalforsamling i SP Group A/S den 25. April 202425.4.2024 14:42:52 CEST | pressemeddelelse
SP Group A/S har i dag, den 25. april 2024 afholdt ordinær generalforsamling. Generalforsamlingen fandt sted i henhold til den annoncerede dagsorden. Bestyrelsen udpegede Advokat Henrik Ottosen til dirigent. Herefter aflagde Formanden, Hans W. Schur, beretning. Administrerende direktør Frank Gad fremlagde selskabets årsrapport. Årsrapporten blev godkendt. Der udbetales et udbytte på DKK 3,00 pr. aktie. Forslag om vederlag til bestyrelsen for det igangværende regnskabsår blev godkendt. Den fremlagte vederlagsrapport blev godkendt. Den fremlagte vederlagspolitik blev godkendt. De fremlagte vedtægtsændringer om bemyndigelse til bestyrelsen blev godkendt. Bestyrelsen trak det fremlagte forslag under dagsordenens pkt. 5.c. (Vedtægternes punkt 5.1 vedrørende bemyndigelse til forhøjelse af selskabskapitalen med fortegningsret for selskabets eksisterende aktionærer) tilbage. Bestyrelsen stillede følgende ændringsforslag til dagsordenspunkt 5.c. (Vedtægternes punkt 5.2 vedrørende bestyrelsens b
Decisions of Annual General Meeting in SP Group A/S25.4.2024 14:42:52 CEST | Press release
On 25 April 2024, SP Group A/S held its Annual General Meeting in accordance with the announced agenda. Henrik Ottosen, Attorney at Law, was Chairman of the Meeting. The Chairman of the Supervisory Board, Hans W. Schur, made his report and thereafter Chief Executive Officer Frank Gad reported on the activities of the Group. The annual report was adopted. A dividend of DKK 3.00 per share was granted. Proposal of remuneration for the Board of Directors for the current financial year was adopted. The presented remuneration report was adopted. The presented remuneration policy was approved. The presented articles of association amendments regarding authorization to the board were adopted. The board withdrew the presented proposal in §§ 5.1 and 5.2. The Board of Directors proposed the following: “The Board of Directors is authorized to increase the share capital without pre-emption rights for the company’s existing shareholders by issuing new shares in one or more rounds of up to a total no
Cortus Energy mottar en beställning av ett bränsleverifieringstest till Japan25.4.2024 14:29:13 CEST | Pressemelding
Stockholm, den 25 april 2024 PRESSMEDDELANDE Cortus Energy har idag fått en beställning från Forest Energy om ett bränsleverifieringstest till ett värde om 170 000 SEK för ett japanskt pappersbruk. Uppdraget kommer att genomföras under sommaren 2024 och syftar till att klarlägga möjligheten att använda en restfraktion av pappersmassa för syngasproduktion med WoodRoll® på det japanska pappersbruket. ”Det är väldigt kul attse marknadsaktörerundersöka förutsättningarna för att använda WoodRoll®i nära anslutning med sina industriella processer. Det ska bli spännande att se vilka möjligheter detta test kan ge upphov till.” Kommenterar Rolf Ljunggren, t.f. VD. För mer information, vänligen kontakta: Rolf Ljunggren, tf. VD, Cortus Energy AB (publ) E-post: rolf.ljunggren@cortus.se Telefon: +46 (0)8 588 866 30 Om Cortus Energy AB (publ) Cortus Energy AB utvecklar och marknadsför den unika WoodRoll®-teknologin som förgasar biomassa på ett nytt innovativt sätt som resulterar i en rad unika fördel
Sportradar Appoints Craig Felenstein as Chief Financial Officer25.4.2024 14:00:00 CEST | Press release
ST. GALLEN, Switzerland, April 25, 2024 (GLOBE NEWSWIRE) -- Sportradar Group AG (NASDAQ: SRAD)(“Sportradar” or the “Company”) today announced that Craig Felenstein has been named Chief Financial Officer of the Company, effective June 1, 2024. Felenstein joins the Company from Lindblad Expeditions (NASDAQ: LIND) where he most recently served as Chief Financial Officer. He will report directly to Sportradar Chief Executive Officer Carsten Koerl. Felenstein brings nearly 30 years of senior finance and operating experience for US publicly listed companies across the media, entertainment, experiential and digital content industries to his new position at Sportradar. Most recently, Felenstein served as Chief Financial Officer at Lindblad Expeditions, a global leader in expedition cruises and adventure travel, where he oversaw the company’s global finance organization, as well their corporate development, information technology and human resources functions. In his role as Sportradar's Chief
Invitation to Harvia’s Capital Markets Day on 29 May 202425.4.2024 14:00:00 CEST | Press release
Harvia Plc press release 25 April 2024 at 3:00 p.m. EEST Harvia invites investors, analysts and media representatives to its Capital Markets Day on Wednesday, 29 May 2024 at 10:30 a.m. EEST. The Capital Markets Day will be held as a hybrid event. Institutional investors, analysts and media representatives are welcome to attend the event in Muurame, Teollisuustie 1–7, Finland. The Capital Markets Day can also be followed as a live webcast at https://harvia.videosync.fi/2024-05-29-cmd. A recording of the webcast and materials will be available after the event at www.harviagroup.com. CEO Matias Järnefelt and other members of Harvia’s Management Team will host the event. During the CMD, the Management Team will present Harvia’s strategy update and targets as well as other topical themes. Those participating in the event on site are requested to register by email to ir@harvia.com by 17 May 2024. Harvia will provide transportation from Helsinki to Muurame and back. In Muurame, the day will a